Stock Analysts’ Downgrades for August, 13th (BGNE, CAJ, CELH, CISN, CPIX, CPST, CSTE, CTO, CVRS, CYTK)

Stock Analysts’ downgrades for Tuesday, August 13th:

Beigene (NASDAQ:BGNE) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company’s clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands. “

Canon (NYSE:CAJ) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Canon, Inc. is an industry leader in professional and consumer imaging equipment and information systems. Canon’s extensive product line enables businesses and consumers worldwide to capture, store and distribute visual information. Canon products include full-color as well as black and white copiers; color laser printers; facsimile machines; micrographics and optical disk filing systems; word processors, typewriters and calculators; camcorders, and lenses; semiconductor, broadcast and optical equipment; and other specialized industrial products. “

Celsius (NASDAQ:CELH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Celsius Holdings, Inc. specializes in commercializing healthier, nutritional functional foods, beverages and dietary supplements. Celsius Holdings, Inc. markets Celsius®, the calorie burner, through its wholly-owned operating subsidiary, Celsius, Inc. The Company sells its products through grocery, drug, convenience, club and mass, and health and fitness channels. The Company’s products are produced in Mooresville, North Carolina, and Monroe, Wisconsin. Celsius, Inc. is dedicated to providing healthier, everyday refreshment through science and innovation. The Company serves customers in the United States and internationally. Celsius Holdings, Inc. is based in Delray Beach, Florida. “

Cision (NYSE:CISN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Cision Ltd. operates as a software company. Its product portfolio consists of PR Software, Social Software, Government Relations and PAC Software, PRWeb and Help a reporter out. The company serves industries which include Pharmaceuticals and Bio-Tech, Banking, Technology, Travel and Hospitality. Cision Ltd, formerly known as Capitol Acquisition Corp. III, is based in Chicago, United States of America. “

Cumberland Pharmaceuticals (NASDAQ:CPIX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company’s lead product candidate, Amelior, which is in phase III clinical trials, is an intravenous formulation of ibuprofen for the treatment of both pain and fever. Its products also comprise Acetadote, an intravenous formulation of N-acetylcysteine for the treatment of acetaminophen poisoning; and Kristalose, a prescription laxative product, which is a crystalline form of lactulose to enhance patient acceptance and compliance. In addition, the company is developing a treatment for fluid buildup in the lungs of cancer patients and an anti-infective for treating fungal infections in immuno-compromised patients. “

Capstone Turbine (NASDAQ:CPST) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Capstone Turbine Corp. develops, designs, assembles and sells Capstone MicroTurbines. Capstone MicroTurbines provide power at the site of consumption and to hybrid electric vehicles that combine a primary source battery with an auxiliary power source, such as a microturbine, to enhance performance. The Capstone MicroTurbine combines sophisticated design, engineering and technology to produce a reliable and flexible generator of electricity and heat for commercial and industrial applications. “

Caesarstone (NASDAQ:CSTE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CaesarStone Ltd manufactures engineered quartz surfaces for residential and commercial buildings as countertops, vanities, wall cladding, floors and other interior surfaces. The company’s product consists of Classico, Supernatural, Motivo and Concetto. CaesarStone Ltd, formerly known as Caesarstone Sdot-Yam Ltd., is based in MP Menashe, Israel. “

Consolidated-Tomoka Land (NYSEAMERICAN:CTO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Consolidated-Tomoka Land Co. is primarily engaged in the real estate industry through its wholly owned subsidiaries. Real estate operations include commercial real estate, real estate development, residential and golf operations, property leasing, leasing properties for oil and mineral exploration and the sale of forest products. “

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Corindus Vascular Robotics, Inc. is involved in designing, manufacturing and selling precision vascular robotic-assisted systems for interventional vascular procedures. The Company’s product includes CorPath 200 system a vascular robotic system which provide stent placement in percutaneous coronary intervention procedures. Corindus Vascular Robotics, Inc. is based in Waltham, Massachusetts. “

Cytokinetics (NASDAQ:CYTK) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology and mechanics of muscle performance, the company is developing small molecule drug candidates engineered to increase muscle function and contractility. Cytokinetics’ lead drug candidate is tirasemtiv, a fast skeletal muscle activator, for the potential treatment of ALS. Tirasemtiv has been granted orphan drug designation and fast track status by the FDA and orphan medicinal product designation by the EMA. Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy. “

DCC (OTCMKTS:DCCPF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “DCC Public Limited Company provides sales, marketing, distribution and business support services. It serves energy, IT and entertainment products, healthcare, environmental services, food and beverage sectors. DCC Public Limited Company is headquartered in Dublin, Ireland. “

Dermira (NASDAQ:DERM) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Its late-stage product candidates comprise Cimzia which has completed Phase II clinical trials for the treatment of moderate-to-severe plaque psoriasis; DRM04 that is in a Phase IIb clinical trial for the treatment of hyperhidrosis or excessive sweating; and DRM01 which has completed a Phase IIa clinical trial for the treatment of acne. Dermira, Inc. is headquartered in Redwood City, California. “

electroCore (NASDAQ:ECOR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Electrocore, LLC operates as a bio-electronic medicine company. It reseraches and develops therapeutic technologies based in neurology and rheumatology. Electrocore, LLC is based in NJ, United States. “

Global Eagle Entertainment (NASDAQ:ENT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Global Eagle Entertainment Inc. offers content and connectivity services for the airline industry. It provides airlines with in-flight video content, e-commerce and information services. Global Eagle Entertainment Inc., formerly known as Global Eagle Acquisition Corp., is headquartered in Los Angeles, California. “

Envestnet (NYSE:ENV) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Envestnet, Inc. is an independent provider of technology-enabled, Web-based investment solutions and services to financial advisors. The Company’s technology platform allows financial advisors to provide their clients with a wide range of investment solutions and services. It offers risk assessment and selection of investment strategies, asset allocation models, research and due diligence, portfolio construction, proposal generation and paperwork preparation, model management and account rebalancing, account monitoring, customized fee billing, overlay services covering asset allocation, tax management and socially responsible investing, aggregated multi-custodian performance reporting and communication tools, as well as access to a range of third-party asset custodians. Envestnet focuses its technology development efforts and its sales and marketing approach on addressing financial advisors’ front, middle and back office needs. Envestnet, Inc. is headquartered in Chicago, Illinois. “

AXA Equitable (NYSE:EQH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “AXA Equitable Holdings Inc. provides financial services which includes investment management insights and advisory solutions. The Company’s operating segments consists of Individual Retirement, Group Retirement, Investment Management and Research, Protection Solutions and Corporate and Other. AXA Equitable Holdings Inc. is based in New York. “

Enerplus (NYSE:ERF) (TSE:ERF) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Enerplus Corporation, formerly known as Enerplus Resources, is an independent oil and gas production company with resources across Western Canada and the United States. The Company’s resource plays include shallow gas/coal bed methane, tight gas, crude oil waterfloods, Bakken/Tight oil and oil sands located in British Columbia, Alberta, Saskatchewan and Manitoba. Enerplus Corporation is based in Alberta, Canada. “

eXp World (NASDAQ:EXPI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “eXp World Holdings, Inc. provides cloud-based real estate brokerage services primarily in the United states and Canada. The company facilitates buyers to search real-time property listings and sellers to list their properties through its Website and provides buyers and sellers access to a network of professional, consumer-centric agents and brokers. eXp World Holdings, Inc., formerly known as eXp Realty International Corporation, is based in Bellingham, Washington. “

Granite Point Mortgage Trust (NYSE:GPMT) was downgraded by analysts at Raymond James to an outperform rating.

Pattern Energy Group (NASDAQ:PEGI) (TSE:PEG) was downgraded by analysts at Raymond James from an outperform rating to a market perform rating.

Receive News & Ratings for Beigene Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beigene Ltd and related companies with MarketBeat.com's FREE daily email newsletter.